The probability distributions of total potential doses of disinfection byproducts and volatile organic compounds via ingestion, inhalation, and dermal exposure were estimated with Monte Carlo simulations, after conducting physiologically based pharmacokinetic model simulations to takes into account the differences in availability between the three exposures. If the criterion that the 95th percentile estimate equals the TDI (tolerable daily intake) is regarded as protecting the majority of a population, the drinking water criteria would be 140 (trichloromethane), 66 (bromodichloromethane), 157 (dibromochloromethane), 203 (tribromomethane), 140 (dichloroacetic acid), 78 (trichloroacetic acid), 6.55 (trichloroethylene, TCE), and 22 μg/L (perchloroethylene). The TCE criterion was lower than the Japanese Drinking Water Quality Standard (10 μg/L). The latter would allow the intake of 20% of the population to exceed the TDI. Indirect inhalation via evaporation from water, especially in bathrooms, was the major route of exposure to compounds other than haloacetic acids (HAAs) and accounted for 1.2-9 liter-equivalents/day for the median-exposure subpopulation. The ingestion of food was a major indirect route of exposure to HAAs. Contributions of direct water intake were not very different for trihalomethanes (30-45% of TDIs) and HAAs (45-52% of TDIs).
Introduction
The health-based drinking water quality criterion for a chemical that has a threshold for its toxicity is derived from the tolerable daily intake (TDI), drinking water intake, and allocation factor (or relative source contribution), which is the fraction of the TDI allocated to intake of drinking water (WHO, 2011) . The derivation is based on the concept that the sum of the daily total exposures from multiple sources should be within the TDI.
When the contribution of water to total daily exposure is unknown, a low value, 10 or 20%, of the allocation factor is traditionally used as a default value based on the protective policy that any additional exposure from water to total exposure should be negligible (Howd et al., 2004; Krishnan and Carrier, 2013) . The use of a low allocation factor is believed to be "generous" to accommodate and account for additional routes of uptake in most cases (Health Canada, 1995; Krishnan and Carrier, 2013) . This policy can be interpreted to mean that water, as a human necessity, should not become a major source of exposure, even if there is no significant exposure from other sources. Therefore, a low value of the allocation factor is applied as long as the health-based drinking water quality criterion derived with the low allocation factor is practically and technically feasible.
An allocation factor other than the low default value is, however, sometimes required, for example when the chemical agent is mainly present in drinking water. An appropriate value of the allocation factor can be used to ensure that an individual's total exposure from multiple sources does not exceed the TDI. However, total exposure varies from one individual to another within a population. Moreover, drinking water intake also varies individually, although the default intake value of 2 L/d is widely and traditionally used in the derivation of healthbased drinking water quality criteria. Use of a range of appropriate intake values is expected to result in a criterion that is protective of a majority of the population.
In the subtraction method of the specific RSC (Relative Source Contribution) approach, sometimes called an Exposure Decision Tree (Gadagbui et al., 2012; USEPA, 2000) , sources of exposure other than drinking water and fish can be considered as background and can be subtracted from the TDI. The estimates of intake from non-water exposures are based on arithmetic mean values of the variable intake of individuals, and the drinking water and fish intake values are 90th percentile estimates. The estimated 90th percentiles of the distributions of daily average per-capita water ingestion by the U.S. population are 2.014 L of community water and 2.341 L of water from all sources (USEPA, 2004) . Although these assumptions are likely protective of a majority of the population, the extent to which they are protective has not been quantitatively determined.
Inhalation and dermal exposures via volatilization of water and dermal contact with water, respectively, are important routes of exposure, in particular for volatile and/or hydrophobic contaminants such as chloroform (Krishnan and Carrier, 2008; Wallace, 1997) . These exposures are evaluated in terms of liter-equivalents per day (Leq/d). The use of Leq's as metrics of exposure is the most appropriate approach in the case of systemically acting contaminants that do not exhibit portal-of-entry effects but are likely to induce the same adverse effect by various exposure routes (Krishnan and Carrier, 2008) . When considering the sum of each daily total exposure from multiple sources in multi-exposure assessments by methods such as the Leq approach, improvements are still envisioned based on consideration of bioavailability, target tissue dose, and extent of absorption via all routes and media (Krishnan and Carrier, 2013) .
Values of Leq/d are actually used to establish drinking water quality criteria in the case of compounds of health concern such as trihalomethanes (Health Canada, 2006) . For volatile organic compounds (VOCs), including trihalomethanes (THMs), tetrachloroethylene (perchloroethylene, PCE, IUPAC name: tetrachloroethene), and trichloroethylene (TCE, IUPAC name: trichloroethene), McKone (1987) has estimated that the indoor-air exposure attributable to tap water is 1.5-6 times the exposure attributable to the consumption of 2 L/d of tap water. Weisel and Jo (1996) have reported that approximately equivalent amounts of the volatile contaminants trichloromethane (TCM) and TCE in water can enter the body by three different exposure routes-inhalation, dermal absorption, and ingestion-as a result of the typical daily activities of drinking and bathing. Jo et al. (2005) have reported that exposure estimates to the THMs [TCM, bromodichloromethane (BDCM), dibromochloromethane (DBCM), and tribromomethane (TBM)] from ingestion of tap water were similar to those from showering. Xu et al. (2002) have suggested that the daily dermal dose of the THMs was approximately 40-70% of the dose from ingestion, while that of haloacetic acids (HAAs) was an insignificant fraction of the daily dose from ingestion. Yanagibashi (2010) has estimated the percentage contribution of ingestion via drinking water to total THM exposure to be 4-24%; the analogous percentages from exposure via inhalation and dermal absorption were 69-94%. These results show that inhalation and dermal contact exposure attributable to tap water may result in exposure equal to or much larger than the exposure from water intake. If the exposures derived from these analyses are converted to units of Leq/d, the total exposure to THMs could be 3-30 Leq/d. The indirect water intake rates (Leq/d values) are basically dependent on exposure scenarios, such as the duration of showering. Therefore, the wide range of the values (3-30 Leq/d) could be partly due to the exposure scenarios assumed. After all, the Leq/d values as well as other intake estimates are associated with a distribution of lifestyles within the population.
Finally, a wide range of intakes from multiple sources is associated with the distributions of lifestyles in a population. Considering the variability of the intakes between individuals, the derivation of Leq's as well as the allocation factor should probably be based on the concept that the sum of the daily total exposures of each individual from all sources should be within the TDI. Whereas the combination of appropriate intake values is expected to result in a criterion that protects a majority of the population, it is quite possible that combining all the high-end intakes for every exposure source is too protective. An approach to characterize the population distribution of intake is the use of probabilistic models that account for the variability of the input parameters related to the exposure scenarios of the population. Niizuma et al. (2013) have conducted assessments of multiple-route exposures to TCM by using a Monte-Carlo approach to create exposure scenarios. They have estimated TCM criteria that provide protection for a majority (95th percentile) of the population. However, their approach has not been used and verified for other contaminants. In their study, moreover, they assumed a constant drinking water consumption rate of 2 L/d for a 50-kg person, but they did not conduct assessments that took into consideration the distributions of daily drinking water intake and body weight. The objective of this study was to extend the multi-route exposure assessment method of Niizuma et al. (2013) by taking into consideration the distributions of daily drinking water intake and body weight. The assessment method was applied to eight compounds for which physiologically based pharmacokinetic (PBPK) models were available (Table 1) . Six compounds were volatile; the other two were not volatile. Six compounds were disinfection byproducts (DBPs). Drinking water quality criteria and Leq/d values that provided protection for a majority (95th percentile) of the population were determined, and allocation factors were discussed. The results were then compared between the eight compounds. Total exposure from multiple sources was evaluated based on the chemical burden in the target organ by using the concept of oral-equivalent potential dose, which takes into account the differences in availability: the ratio of the biologically effective dose at the site of toxic action per potential dose (administered dose) via oral exposure, inhalation, or dermal exposure.
Methods

Total oral-equivalent potential dose
Exposure route is important in determining toxicity. Ingested compounds are metabolized during the first pass through the liver, whereas inhaled and dermally permeated compounds pass directly into the general circulation (Weisel and Jo, 1996) . Therefore, simple summation of potential exposure or administrated dose is not appropriate, even if a target compound induces the same adverse effect by multiple exposure routes. It is necessary to know the biologically effective dose at the site of activity (a target organ) of a contaminant. A PBPK model relates the potential exposure to the biologically effective dose (Wallace, 1997) . Niizuma et al. (2013) have conducted a PBPK model simulation of TCM to calculate equal biologically effective doses from potential exposures via various exposure routes. They proposed an equation for total oral-equivalent potential dose via three routes (oral ingestion, inhalation, and dermal exposure). The oral-equivalent potential dose is a normalized potential dose in which a biologically effective dose associated with inhalation or dermal exposure is converted into a hypothetical potential dose from oral ingestion with the same equivalent biologically effective dose. For example, when the oral-equivalent potential dose of inhalation is 1 mg/(kg d), that dose produces the same [mg/(kg day)]
VSD at 10
VSD at 10 biologically effective dose as an oral potential dose of 1 mg/(kg d). The total oral-equivalent potential dose via three routes (oral ingestion, inhalation, and dermal exposure) is given by (Niizuma et al., 2013 ):
(1)
The value of the relative availability for inhalation/oral exposure (R 2/1 ) was estimated by using Equation (2) with the results of PBPK model simulation.
Similarly, the value of the relative availability for dermal/oral exposure (R 3/1 ) was estimated by using Equation (3).
For the estimations of the AUC (area under the curve) values of the THMs, we used the same PBPK model as that of Niizuma et al. (2013) , which is structurally similar to previous models (Corley et al., 1990 (Corley et al., , 2000 Ramsey and Andersen, 1984; Tan et al., 2006b) (Fig. SA1 , Table  SA1-1, and Table SA1 -2 Supplementary Information A). The TDIs of THMs are determined from administered doses based on the incidence of hepatic cysts (Table 2) . Hepatic cytotoxicity following exposure to THM is primarily related to rates of THM metabolism (Lévesque et al., 2000 (Lévesque et al., , 2002 Liao et al., 2007; Reitz et al., 1990; Sasso et al., 2013; Tan et al., 2003) . Therefore, the AUCs were obtained in plots of the rates of THM metabolism in liver vs. time.
For dichloroacetic acid (DCAA), we applied the model of Li et al. (2008) after incorporating a component for dermal adsorption (Poet et al., 2000) (Fig. SA3 , Table SA3-1, and Table SA3 -2, Supplementary Information A). For trichloroacetic acid (TCAA), we applied the model of Fisher et al. (1998) after incorporating a component for dermal adsorption (Poet et al., 2000) (Fig. SA2 , Table SA2-1, and Table SA2 -2, Supplementary Information A). Because the TDI values of the HAAs were determined on the basis of hepatic toxicity (Table 3) , the AUCs were obtained in plots of the HAA concentrations in the venous blood leaving the liver vs. time.
For TCE, we applied published models (Clewell et al., 2000 (Clewell et al., , 2001 ; Fisher et al., 1998) after incorporating a component for dermal adsorption (Poet et al., 2000) (Fig. SA4 , Table SA4-1, and Table SA4 -2, Supplementary Information A). For PCE, we applied published models (Clewell et al., 2001; Covington et al., 2007; Fisher et al., 1998) after incorporating a component for dermal adsorption (Poet et al., 2000 (Poet et al., , 2002 (Fig. SA5 , Table SA5-1, and Table SA5 -2, Supplementary Information A). Because the TDI value of the TCE is determined on the basis of developmental toxicity to the fetal heart and the developmental toxicity is associated with TCE's metabolites, trichloroacetic acid (TCAA) (Johnson et al., 1998a; Johnson et al., 1998b; USEPA, 2011a; USEPA, 2011b) and dichloroacetic acid (DCAA) (Epstein et al., 1992; Smith et al., 1992; USEPA, 2003) , the AUCs were obtained in plots of the TCAA and DCAA concentrations in placenta vs. time, as well as in the plots of TCE concentration vs. time, after the administration of TCE (Table 2 and Table SB1 , Supplementary Information B).
The TDI of PCE was determined based on the incidence of hepatic cysts and the hepatotoxic effect is thought to be due to the PCE's metabolite, TCAA (USEPA, 2012; WHO, 2003) . The AUCs for PCE were, therefore, obtained in plots of the TCAA concentrations in the venous blood leaving the liver vs. time, as well as in the plots of PCE concentration vs. time, after the administration of PCE.
The PBPK models were solved with the relevant parameter values (Supplementary Information B) by using Mathematica 10 (Wolfram Research, Champaign, IL, USA) to estimate AUC values, and then the values of R 2/1 and R 3/1 were estimated from the AUC values by using equations (2) and (3), respectively.
Monte-Carlo and multi-exposure assessment
We calculated the probability distribution functions for total oralequivalent exposure via the three routes (ingestion via drinking water and food, inhalation, and dermal absorption) by using Equation (1) for given concentrations of target compounds in drinking water and Monte Carlo inputs (Crystal Ball 2000, Japanese edition, Kozo Keikaku Engineering Inc., Tokyo, Japan) with 10 5 trials and a random number sampling method (Latin Hypercube Sampling). The basic structure of the procedure is shown in Fig. SB1 (Supplementary Information B) . Monte Carlo inputs were those related to the characterization of the exposure scenarios, that is, rates of food and water intake, concentrations in the air, inhalation exposure times, and dermal exposure times. Niizuma et al. (2013) have applied the Monte Carlo method and estimated the probability distributions of TCM exposures via food consumption, inhalation (concentrations in the air and inhalation exposure times), and dermal contact (exposure times) by using exposure concentration data (Itoh and Asami, 2010) , nutrition survey data (MHLWJ, 2006) , and data for exposure time (NHK-BCRI, 2006; ULRI, 1999) . In this study, we basically followed the method of Niizuma et al. (2013) and used the data from these data sources. When data were not available, we predicted data by extrapolation from existing data (details may be found in Supplementary Information B). Beside the inputs via the method of Niizuma et al. (2013) , the oral intake rate of drinking water was a random number chosen from a probability distribution function (a Monte Carlo input). The distribution of water consumption rates that we used for the Monte Carlo-simulated inputs is shown in Fig. SB7 (Supplementary Information B) . We also considered the variability of the body weights of Japanese adults. Body weight was a random number chosen from the distribution of body weights of Japanese adults (Fig. SB8, Supplementary Information  B) . Physiological model parameters (alveolar ventilation rate and exposed body surface area) were determined as a function of body weight according to the following equations (Clewell et al., 2001; Tan et al., 2006a ):
There were weak correlations between body weight and the random values of food and water intake (Fig. SB9, Supplementary Information  B) . Overall, Monte Carlo inputs were based on data for ordinary Japanese adults. The inputs, therefore, did not take into consideration children and special subpopulations, such as population occupationally exposed to the target compounds.
Results and discussion
3.1. R 2/1 and R 3/1 value determination for estimating oral-equivalent potential dose 3.1.1. THMs The PBPK model simulations for the THMs were conducted for oral doses, inhalation concentrations, and dermal exposure concentrations, and the AUCs were estimated. Substituting the AUCs into Equations (2) and (3) yielded R 2/1 and R 3/1 values, respectively. The results of the calculation are shown in Table SB1 (Supplementary Information B) . R 2/ 1 and R 3/1 values were independent from oral doses, inhalation concentrations, and dermal exposure concentrations, and therefore R 2/1 and R 3/1 values were determined for each compound. Table 3 summarizes the determined R 2/1 and R 3/1 values.
That the R 2/1 and R 3/1 values of the THMs were all lower than 1 means that inhalation and dermal exposures resulted in a lower burden to the liver than oral exposure did at the same potential dose. If potential exposures were simply used as the relevant dose metric, therefore, the degree of toxicity from inhalation and dermal contact would be somewhat overestimated compared to the toxicity from oral ingestion. The R 2/1 values were lower for the compounds with higher volatility (lower blood/air partition coefficient, P ba ), probably because the inhalation intake calculated using Equation (8) becomes smaller (Chiu and White, 2006; Niizuma et al., 2013 ).
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However, the blood/water partition coefficient (P bw ) (Table SA1 -2) was not strongly related to the R 3/1 values. Compounds taken in through dermal exposure can be eliminated through inhalation when the compounds are volatile.
Highly volatile compounds (low blood/air partition coefficient, P ba ) such as TCM have high rates of elimination according to Equation (9). 
Therefore the R 3/1 values are lower for the compounds with higher volatility. For every compound, the R 2/1 value for inhalation exposure was similar to the R 3/1 value for dermal exposure.
HAAs
The values of R 2/1 and R 3/1 were determined by the same procedure used to estimate the analogous ratios for the THMs (Table SB1 , Supplementary Information B and Table 3 ). The R 3/1 and R 2/1 values of TCAA and DCAA were all 1.0, which would be due to the almost none volatilities of TCAA and DCAA and their blood/air partition coefficient (P ba ) values are therefore high, as discussed in the previous section.
VOCs
The PBPK model was applied to both TCE and its metabolites (DCAA and TCAA) to estimate target tissue doses for the induction of developmental toxicity: the target organ was the placenta, through which TCE and its metabolites pass to the fetus. AUC of TCE and its metabolites in the placenta were calculated for several oral doses, inhalation concentrations, and dermal exposure concentrations of TCE, and the values of R 2/1 and R 3/1 were determined by the same procedure used to estimate the analogous ratios for THMs (Table SB1 , Supplementary  Information B) . The values of R 2/1 and R 3/1 were greater than 1.0 for TCE and less than 1.0 for the metabolites. Ingested TCE is metabolized during the first pass through the liver, and then it is delivered to the placenta via systemic circulation. However, both inhaled and dermally absorbed doses are delivered directly via systemic circulation and are not modified by first passing through the liver. Therefore, inhaled and dermally absorbed doses are delivered at a higher rate than an ingested dose, the result being that R 2/1 and R 3/1 are larger than 1 for TCE. In contrast, because the concentrations of DCAA and TCAA are increased rather than decreased as a result of the passage of TCE through the liver, their R 2/1 and R 3/1 values are less than 1. In the following exposure estimations (Section 3.2), the values of R 2/1 and R 3/1 determined for the metabolites DCAA and TCAA were used for the following exposure assessment of TCE because the metabolites are thought to be responsible for the toxicity (USEPA, 2011b).
The TDI of PCE was determined from administered doses based on the incidence of hepatic cysts (Table 2 ). We calculated concentrations of both PCE and its metabolite (TCAA) in the venous blood leaving the liver for several PCE oral doses and inhalation and dermal concentrations, and the values of R 2/1 and R 3/1 were determined by the same procedure used to calculate the analogous ratios for THMs (Table SB1 , Supplementary Information B, Table 3 ). The R 2/1 and R 3/1 values were consistent with the trend obtained for the THMs: the R 2/1 and R 3/1 values were lower for the compounds with higher volatility (low blood/ air partition coefficient, P ba ). The values of R 2/1 and R 3/1 of the metabolite TCAA were used in the following exposure assessment of PCE because the hepatotoxic effects of PCE is thought to be due to the metabolite TCAA (USEPA, 2012; WHO, 2003) .
Exposure assessment
The probability distributions of the total oral-equivalent potential dose were calculated for given concentrations in drinking water by the Monte Carlo method. A drinking water concentration that yielded a 95th percentile estimate equal to TDI (95% of estimates ≤ TDI) would be protective for a majority of the population, assuming that the upper 95% confidence limit is a useful indicator of high-end exposure (Nakanishi et al., 2006; Nitta et al., 2003; Nougadère et al., 2011; USEPA, 2000) . These concentrations were also calculated for the eight target compounds.
THMs
If drinking water contained the THMs of the JDWQS concentrations, the probability that the daily intake of any one of them would exceed its respective TDI was very low (Fig. SC1, Supplementary Information C) . The JDWQS values are therefore protective for the majority (> 95%) of the population, but at the same time the JDWQS values may be somewhat conservative.
A TCM concentration of 140 μg/L yielded a 95th percentile estimate of daily TCM intake equal to the TDI of 12.9 μg/(kg d) ( Table 2 ). In other words, when people drink and use water with a TCM concentration equal to 140 μg/L every day, the 95th percentile of the cumulative distribution of daily TCM intake is 12.9 μg/(kg d). The median is 7.1 μg/(kg d). Fig. 1A shows the median and 95th percentile estimates and their breakdown (% ratio to the TDI) with respect to exposure routes. For the median-exposure (the 50 th percentile estimate) subpopulation, the intake of TCM via direct consumption of drinking water was 28% of the TDI, and it was 43% for the high-end exposure subpopulation (the 95th percentile estimate). The percentages of 28% and 43% resulted from water intakes of 1.27 and 1.98 L/d, respectively, for a person of a 50-kg body weight, which is the default assumption in determining JDWQS values. If a 50-kg person (default values used in determining the JDWQS values) drinks water containing TCM (140 μg/ L) at a rate of 2 L/d, the exposure from this intake would be 5.6 μg/(kg d), which is 43% of the TDI. The difference between the median and high-end exposure was partly due to the difference of water intake, but the difference was primarily caused by the difference of inhalation exposures (Niizuma et al., 2013) . Dermal absorption did not contribute much to the total exposure. The reasons of the small contribution are presented elsewhere (Niizuma et al., 2013) , but briefly this is due to the differences exposure scenarios, employed skin permeability coefficient values and relevant dose metrics. In the previous study in which drinking water intake rate was fixed to 2 L/d, the concentration that causes the 95th percentile dose equal to the TDI was 110 μg/L (Niizuma et al., 2013) : that is lower than the concentration of 140 μg/L obtained in this study. The lower concentration would reflect that the 2 L/d intake rate is higher than the actual intake rate: for median exposure subpopulations it was 1.27 L/d and even for the high-end exposure subpopulations it was 1.98 L/d.
For BDCM, a concentration of 66 μg/L, which is larger than the JDWQS, yielded a 95th percentile estimate equal to the TDI of 6.1 μg/ (kg d). The median estimate was 3.3 μg/(kg d) (Fig. 1B) . The contributions from each exposure route were similar to those of TCM.
For DBCM, a concentration of 157 μg/L, which is larger than the JDWQS, yielded a 95th percentile estimate equal to the TDI of 21 μg/ (kg d). The median estimate was 8.8 μg/(kg d) (Fig. 1C) . That the contribution from inhalation exposure was higher for DBCM than for BDCM and TCM could be due to the larger effect of evaporation of DBCM from water (high b k (r) value, Table SB2 , Supplementary  Information B) .
A TBM concentration of 203 μg/L, which is larger than the JDWQS, yielded a 95th percentile estimate equal to the TDI of 17.9 μg/(kg d) (Fig. 1D) . The median estimate was 9.9 μg/(kg d). That the contribution from inhalation exposure was somewhat lower for TBM than for BDCM and TCM could be due to the lower evaporation rate of TBM: the Henry's law constant and the transfer efficiency of TMB were the lowest among the THMs (Table SB1, Supplementary Information B) .
The concentrations of all the THMs that yielded 95th percentile estimates identical to the corresponding TDI were larger than the corresponding JDWQS values. Drinking water containing these THM concentrations at a rate of 2 L/d would result in oral exposure from the drinking water equal to 30-45% of the corresponding TDIs (Table 2) . These percentages are higher than the default allocation factor of 20% M. Akiyama et al. Regulatory Toxicology and Pharmacology 95 (2018) [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] that is applied in setting the JDWQS. A comparison with the WHO guideline values (Table 2) revealed that the concentrations associated with the 95th percentile estimates were lower for TCM and very similar for BDCM. For TCM, the 95th percentile estimate (140 μg/L) was about 1/2 of the WHO guideline value (300 μg/L). The TCM WHO guideline value of 300 μg/L would therefore not be applicable to Japan. The WHO value of 300 μg/L was derived by allocating 75% of the TDI to drinking water (WHO, 2011) . However, the WHO guideline also suggests a value lower than 300 μg/ L, such as 150 μg/L, for cases where much exposure comes from routes other than ingestion: inhalation of indoor air with a high TCM concentration due largely to volatilization from drinking water and inhalation and dermal exposure during showering or bathing. This scenario applies to Japan, a country where people take showers and bathe frequently (Niizuma et al., 2013) . Consequently, we feel that a value lower than 300 μg/L would be reasonable as the JDWQS for TCM.
For the median-exposure (the 50 th percentile estimate) subpopulation, indirect consumption of water amounted to 1.16-1.47 Leq/d, which accounted for 22-27% of the TDIs (Fig. 1 and Table 2 ). For the high-end exposure (the 95th percentile estimate) subpopulation, Fig. 2 . Total oral-equivalent potential doses of DCAA and TCAA (Panels A and B, respectively) when the 95th percentile estimates were equal to the corresponding TDIs. The second and third bars show the median (50th percentile) and the 95th percentile estimates, respectively. The DCAA and TCAA concentrations in drinking water were equal to 140 and 78 μg/L, respectively.
indirect consumption of water was 2.4-5.1 Leq/d, which accounted for 55-76% of the TDIs. For the high-end exposure populations, maximum acceptable concentration derived by equation (10) for each compound are also listed in Table 2 . The concentrations were larger than the corresponding JDWQS and WHO guideline values.
The high indirect exposures of THMs were due to evaporation from water. Dermal contact accounted for less than 6% of total exposure, which is lower than the percentages reported previously (Kim et al., 2004; Xu et al., 2002; Yanagibashi, 2010) . The reason for the low dermal exposure is discussed by Niizuma et al. (2013) . Briefly, our study dealt with internal exposure, whereas the previous studies dealt with potential exposure. The low percentage associated with dermal contact was also due to the difference in exposure scenarios: our study dealt with total daily exposure, whereas the other studies compared inhalation and dermal exposures only during bathing.
Differences in inhalation exposure scenarios made the 95th percentile estimate much larger than the median estimate. The large amount of exposure from inhalation was caused mainly by the high THM concentrations in the inhaled air and not by longer exposure time (Fig. SC2 , Supplementary Information C) (Niizuma et al., 2013) .
HAAs
For DCAA and TCAA, the concentrations that resulted in 95th percentile estimates equal to the TDI were 140 and 78 μg/L, respectively ( Fig. 2 and Table 2 ). These values were both larger than the corresponding JDWQS and WHO guideline values. The JDWQS value for TCAA is based on its TDI, but our results (Fig. SC3 , Supplementary Information C) indicated that the probability that the total daily intake of TCAA might exceed the TDI was very low even if drinking water contained TCAA at its JDWQS concentration. Therefore, the JDWQS value for TCAA is protective for the majority (> 95%) of the population, but it may be conservative. For DCAA, in contrast, the JDWQS value of 30 μg/L was derived from a virtually safe dose (VSD) for a water intake of 2-L/d at a risk of 10 −5 in the unit cancer risk approach because this value was lower than the value of 140 μg/L, which was derived from the TDI of 12.5 μg/(kg d) and an allocation factor of 10%. Our result clearly indicates that the JDWQS value of 30 μg/L, which was derived with the unit cancer risk approach, provides a margin of safety in terms of non-cancer assessment on the TDI. When one drinks water containing DCAA (140 μg/L) and TCAA (78 μg/L) at a rate of 2 L/d, the oral exposure from the drinking water accounts for 45-52% of the respective TDIs (Fig. 2) . These percentages are higher than the default value of 20% that is applied in setting the JDWQS. The contributions from dermal and inhalation exposures were very low. Similar insignificant contributions from dermal and inhalation exposures can be predicted from skin permeability coefficients and volatilities (Krishnan and Carrier, 2008) . It should be noted that for high-end exposure, 40-54% of the total exposures was accounted for by food intake, whereas food intake accounted for 24-31% of total exposure for the median-exposure group. Cooking food with water raised the HAA concentrations and then the exposure via food intake, which originated from the cooking water. Therefore, indirect exposure via food was the major exposure route for the HAAs, which are not volatile compounds. In contrast, for the THMs, which are volatile compounds, indirect exposure via inhalation was the major exposure route, as described in subsection 3.2.1. Indirect water intakes for DCAA and TCAA exposure were 1.4 and 1.0 Leq/d, respectively, for the median-exposure subpopulation; they were 2.4 and 1.6 Leq/d, respectively, for the highend exposure subpopulation. These values are not small, even when compared with those for the THMs. The difference in exposures via food intake made the 95th percentile estimate much larger than the median estimate (Fig. 2) . Per-capita water and food consumption were large for people with large body weights, but consumption per unit body weight was somewhat larger for people with relatively low body weights (Matsui, 2013) . Therefore, a relatively large rate of food and water intake per unit body weight for the low-body-weight subpopulation might have been a major cause of their high exposure. Actually, the body weights of the high-exposure subpopulation were somewhat smaller than those of the median-exposure subpopulation (Fig. SC4,  Supplementary Information C) . However, exposure distributions did not vary much as a function of body weight (Fig. SC5, Supplementary  Information C) . Persons in the low-body-weight subpopulation would not be vulnerable, despite their relatively large rate of food and water intake per unit body weight.
DBPs, including THMs and HAAs, are usually not detected in high concentrations in uncooked foods and natural air (Itoh and Asami, 2010) . However, allocation factors are not assigned large percentage values for drinking water in Japan, partly because of consideration of the contributions of indirect exposure, possibly via inhalation. A single, small default value of 20%, which is allocated to ingestion of drinking water at a rate of 2 L/d, is used as the allocation factor of DBPs (both THMs and HAAs), although the physical and chemical properties that affect volatility are very different for THMs and HAAs. HAAs are not volatile compounds, whereas THMs are volatile. Therefore, we had anticipated that the contributions of water intakes derived in this study would have been very different for THMs and HAAs. However, the contributions derived in this study were not very different: they were 30-45% of the TDIs for THMs and 45-52% for HAAs. Ingestion of food was a major indirect route for HAAs, whereas inhalation was a major indirect route for THMs due to volatilization from drinking water. If the smallest percentage derived in this study, 30%, is adopted as the overall allocation factor for DBPs to ensure that the policy is protective, then the current default allocation factor of 20%, which is not so different from that value, is consistent with the goal of protection and is supported by the results of this study.
VOCs
Fig . 3A shows the probability distribution of total oral-equivalent potential dose when the TCE concentration in water is 10 μg/L (the JDWQS value). Under this condition, about 20% of the population exceeds the TDI of 1.46 μg/(kg d). The concentration of TCE that resulted in a 95th percentile estimate equal to the TDI of 1.46 μg/(kg d) (5% of the population exceeds the TDI) was 6.55 μg/L (Table 2, Figs. 3A and  4A ).
In the derivation of the current JDWQS value, 70% of the TDI was allocated to ingestion of drinking water at a rate of 5 L/d, which is 2 L/d for direct intake plus 3 Leq/d for indirect intake via volatilization from water based on Equation (10). Our calculations indicate that indirect intake via inhalation of air containing TCE volatilized from water is the major source of exposure, and indirect intake is much larger than direct intake from drinking water (Fig. 4A) . The estimated indirect water intake rates were mostly larger than 3 Leq/d, which is applied in the derivation of the current JDWQS value. They were 3.1 Leq/d for the median-exposure subpopulation (the 50 th percentile estimate) and 9.1 Leq/d for the high-end exposure (the 95th percentile estimate) subpopulation. These values were also much larger than those of the THMs. It should be due to the high evaporation rate of TCE. The Henry's law constant for TCE is more than two times that of the TMHs, and the transfer efficiency of TCE was therefore more than two times that of the THMs (Table SB1 of Supplementary Information B). The observed TCE Fig. 4 . Total oral-equivalent potential doses of TCE and PCE (Panels A and B, respectively) and their breakdown products when the 95th percentile estimates were equal to the corresponding TDIs. The second and third bars shows the median (50th percentile) and the 95th percentile estimates, respectively. The TCE and PCE concentrations in drinking water were equal to 6.55 and 22 μg/L, respectively.
concentrations in air and water in bathrooms, however, indicate that the intensity of TCE evaporation is around 3.75 times that of TCM (Fig.  SB3 of Supplementary Information B), the suggestion being that the indirect water intake rate through evaporation should be much higher for TCE than the THMs. For the high-end exposure subpopulation, the indirect water intake rate was very high, 9.1 Leq/d. Most of the indirect water intake was caused by inhalation in the bathroom. High TCE concentrations in bathroom air would produce a high-end exposure subpopulation (the 95th percentile estimate). Such high concentrations could be caused by low ventilation rates in the rooms and/or any activities that cause high rates of TCE evaporation from water, as suggested by Niizuma et al. (2013) . It should also be noted that total oral-equivalent potential dose values and Leq/d values are changed depending on model parameter and input values. The large contribution of inhalation to total exposure indicates that the model parameter and input for inhalation exposure [R 2/1 and C a in equation (1)] influence the results of total oral-equivalent potential dose. The high TCE evaporation rate and long bathing/ showering time raise the daily-average concentration in inhaled air (C a ), as discussed earlier. In the simulation which produced the results of Figs. 3A and 4A, the R 2/1 value of the TCE' metabolites was applied because of the general consideration that the TCE toxicity reside in its metabolites (USEPA, 2011b) . When the R 2/1 values for the TCE, which is 4 times as large as those of the metabolites, was applied in the simulations, the contribution of inhalation exposure becomes higher: the indirect intake via inhalation increased by about 4 times (e.g., from 3.1 to 13.5 L/d for the median-exposure subpopulation (compare Fig. 4A and Fig SC6 of Supplementary Information C) . The concentration of TCE that resulted in a 95th percentile estimate equal to the TDI of 1.46 μg/(kg d) became smaller: it was 1.6 μg/L (Fig SC7 of Supplementary  Information C) . Therefore, the outcome of the simulation is sensitive to the R 2/1 value as well as exposure scenarios for inhalation. The value of R 2/1 is determined depending on the mode of action for toxicity, while the exposure scenarios are dependent on local conditions including long-time showering and bathing and/or in poorly ventilated buildings.
Figs. 3B and 4B show the results for PCE. The concentration that resulted in the 95th percentile estimate equaling the WHO TDI of 14 μg/(kg d) was 22 μg/L (Table 2) , roughly twice the JDWQS value of 10 μg/L. The JDWQS value was derived from a VSD for a water intake of 2-L/d at a risk of 10 −5 in the unit cancer risk approach because the value of 10 μg/L was lower and on the safer side than the value of 40 μg/L, which was derived from the TDI of 14 μg/(kg d) and an allocation factor of 10%. Our results clearly indicate that the JDWQS of 10 μg/L, which was derived from the VSD in the unit cancer risk approach, includes a margin of safety in terms of the non-cancer assessment on the TDI. It should also be noted that the indirect intake of PCE was very high: it was 9 Leq/d for the median-exposure sub-population. This is due to the high evaporation rate of PCE. The intensity of PCE evaporation was around 12 times that of TCM (Fig. SB5 of Supplementary Information B).
Summary
For THMs and TCAA, concentrations that caused the 95th percentile estimate to equal the corresponding TDI were higher than the corresponding JDWQS values, which are based on TDI values with an allocation factor of 20%. For DCAA and PCE, the JDWQS values of 30 and 10 μg/L, respectively, which are derived from the VSD for a water intake of 2 L/d and a risk of 10 −5 in the unit cancer risk approach, provided a margin of safety in terms of non-cancer risk assessment: the probabilities that the intakes would exceed the TDIs were below 5%. When the TCE concentration in water equals the JDWQS value of 10 μg/L, we estimated that the TCE intake of about 20% of the population would exceed the TDI. The high TCE exposure of the population was due to the high TCE concentrations in bathroom air; it had little to do with other characteristics, such as direct intake from water and food and low body weight. The TCE concentration that causes the 95th percentile estimate to equal the TDI was 6.55 μg/L, which is lower than the JDWQS value. The contributions of indirect water intake for HAAs were not very different from those derived for THMs. Ingestion of food, however, was a major indirect route of exposure for HAAs, whereas inhalation was a major source of exposure to THMs because of volatilization from drinking water. For the median-exposure population, indirect water intake of the eight compounds ranged from 1 to 9 Leq/d. The indirect water intake rate through evaporation was much higher for TCE and PCE than TCM. The intensities of TCE and PCE evaporations in bathroom was higher than those estimated from the Henry's law constant the transfer efficiency.
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